The NZZ accompanied Adon Health and Dr. Jonathan Apasu, physician and co-founder of Adon Health, as part of the documentary film "Testosterone Boom: Medicine or Business?" The documentary draws attention to a topic that deserves more visibility and nuanced classification in public discussion.
At the same time, it illustrates the tension in which the market currently operates: On the one hand, testosterone deficiency represents a real medical care problem. On the other hand, affected patients still encounter care structures that are often too slow, too unclear, or difficult to access. Against this background, digital models can make an important contribution, provided they are designed in a medically responsible manner.
Parallel to this, there is a clear hype surrounding biohacking and longevity. In this environment, more and more market players are positioning themselves who do not consider the topic of testosterone with sufficient nuance. This further complicates the public debate and can reinforce rather than reduce existing stigmas.
Therefore, a clear classification is all the more important: Testosterone therapy is medicine. It should not be mixed with lifestyle promises or short-term trends. This distinction is crucial for responsible handling of diagnostics, indication, and therapy.
In this context, Adon Health takes a clear position in terms of medical integrity. Therapy decisions are made independently of Adon Health by cooperating physicians. There are no financial incentives for prescriptions. Adon Health's role is to provide a digital infrastructure that can make medical processes more accessible, structured, and patient-centered.
The documentary shows that the topic is socially relevant and the challenges in care are real. The NZZ addressing this tension is an important contribution to raising awareness of men's health. Crucial to this remains an objective discussion, medical differentiation, and the further development of sustainable care pathways for affected patients.
